Source: Inflammation Research. Conference titles: World Congress on Inflammation. Unidade: FCF
Subjects: AMBLYOMMA CAJENNENSE, BIOQUÍMICA
ABNT
FARSKY, Sandra Helena Poliselli et al. Amblyomin-X, a Kunitz-type serine protease inhibitor, impairs in vivo VEGF-induced angiogenesis. Inflammation Research. Basel: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2011APA
Farsky, S. H. P., Drewes, C. C., Dias, R., Hebeda, C. B., Simons, S. M., & Chudzinski-Tavassi, A. M. (2011). Amblyomin-X, a Kunitz-type serine protease inhibitor, impairs in vivo VEGF-induced angiogenesis. Inflammation Research. Basel: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Farsky SHP, Drewes CC, Dias R, Hebeda CB, Simons SM, Chudzinski-Tavassi AM. Amblyomin-X, a Kunitz-type serine protease inhibitor, impairs in vivo VEGF-induced angiogenesis. Inflammation Research. 2011 ; 60 86.[citado 2024 nov. 04 ]Vancouver
Farsky SHP, Drewes CC, Dias R, Hebeda CB, Simons SM, Chudzinski-Tavassi AM. Amblyomin-X, a Kunitz-type serine protease inhibitor, impairs in vivo VEGF-induced angiogenesis. Inflammation Research. 2011 ; 60 86.[citado 2024 nov. 04 ]